Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial cellular components, including the cell membrane, lipids, proteins, and DNA, constitute the fundamental targets for the majority of known antimicrobial therapies. The bacterial cell wall and membrane provide structural protection and selective permeability; they are targeted by classes such as beta-lactams and polymyxins to induce cell lysis [1]. Bacterial proteins, specifically those involved in the 30S and 50S ribosomal subunits, are essential for translating genetic information into functional enzymes and structures, making them targets for aminoglycosides and macrolides [2]. DNA and its associated enzymes, such as DNA gyrase and topoisomerase IV, are vital for the replication and transcription of the bacterial genome and are inhibited by fluoroquinolones [3]. These targets are critical for bacterial survival and pathogenesis, and their disruption is the primary mechanism for treating bacterial infections [4]. However, the broad targeting of these components can lead to significant safety concerns, including the development of multi-drug resistance and the destruction of beneficial commensal microflora [5]. Sources: [1] StatPearls, Antibiotics (NBK535444); [2] Nature Reviews Microbiology, Ribosome-targeting antibiotics (PMID: 24590204); [3] Encyclopedia of Microbiology, Antimicrobial agents; [4] Cold Spring Harbor Perspectives in Biology, The Bacterial Cell Envelope (PMID: 20452953); [5] Nature, Stop the killing of beneficial bacteria (PMID: 21866137).
Inhibition of cell wall peptidoglycan synthesis, disruption of cytoplasmic membrane integrity, inhibition of protein synthesis via ribosomal binding, and inhibition of nucleic acid synthesis through DNA gyrase or RNA polymerase interference.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cellular components (Membranes, Lipids, Proteins, and DNA).